the kid has a lot of risk factors, comorbid conditions, i would recommend the vaccine. if the kid is natural immunities from prior infections, they don t need the vaccine. the complications are higher in boys than girls, so you may want to space out that second dose or skip it in young boys for now. john: in terms of distribution, the white house says that it has about 28 million doses of the vaccine. that is an answer to every child in america between 5-11. they will make it available at pediatrician offices i m a primary care sites, hospitals, pharmacies, schools. that is a different strategy than the adult vaccine which has not been available in your local doctor s office. it is, and this is a good move by the department of health and human services. they want to encourage conversations about vaccinating kids with a pediatrician. they are very skilled at having these tailored conversations. it will not be the sort of thing where we see a lot of kids getting at the local pharmacy
years 94% vaccinated. with an adult vaccine where there s some discretion whether or not people take it i don t know that we re able to achieve levels much above 85, 86%. if we get there, it s quite a good result. if we were dealing with the old wuhan variant, or b.1.1.7. if we had 78% of the people vaccinated. that would be quite a wall of immunity. we re dealing with a much more contagious variant in this delta variant. dr. gottlieb, thank you for being with us, dr. scott gottlieb, a member of pfizer s board of directors and the author of uncontrolled spread why covid-19 crushed us and how we can defeat the next pandemic, we appreciate your time tonight. still ahead some important developments as the biden justice department takes on texas.
solve covid? i certainly hope, not i suspect on the margins it will, the idea that there s a drug available for people that will. we need to contain and push all the things we re doing to get more people vaccinated, the bottom line is if you look at pediatric vaccinations, where we have mandates in place, vaccines are requirements go to school. the measles mumps and rubella vaccine, looking back over the last ten years, you get about 90% of kids vaccinated in the best years will get about 94% vaccinated, so with an adult vaccine, where there s some discussion whether or not people take it, i don t know that will be able to achieve levels much above 85 86%. i think as we get there it s quite a good result, remember, if we were dealing with the wuhan variant, or even if we had 78% of the adult population vaccinated, that would be a pretty profound wall of immunity, and the reason why we need to get more in the public vaccinated, is because we re dealing with a much more contagious vari
kids in the trial had a strong immune response, with just a third of the dose given to older children than adults. it will not be applying for emergency authorization for the child sides doses from the fda, by the end of the month. and if the fda approves the application as quickly as they did with the adult vaccine, think it could be getting vaccinated as early as halloween. parents will no doubt have all sorts of questions about this news, and what comes next, i another parent certainly do. so i want to bring in doctor dr. richard besser former acting director of the center of disease control and prevention. dr. richard besser, first let s start with the data we don t have all of it i think. we get this sort of first summary version of from pfizer. but what is your reaction to what we know so far about